🇩🇪 Germany · EU Public Tender
Vertragsschluss nach 130c SGB V SKYRIZI® Wirkstoff: Risankizumab ATC-Code: L04AC18
🏛️ AOK Bayern – Die Gesundheitskasse · 📍 München
1 €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | AbbVie Deutschland GmbH & Co. KG |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.